Advancing the delivery of glucagon

Gvoke is the first and only ready-to-use liquid glucagon1,2

Using Xeris' nonaqueous formulation technology, Gvoke addresses the stability and solubility issues that arise from traditional glucagon kits to become the first and only ready-to-use liquid glucagon.1,2


The Gvoke Pre-Filled Syringe (PFS)1
side view of the Gvoke Pre-Filled Syringe
  • Premixed, prefilled, and premeasured glucagon, so it is easy to use3
  • Simple 2-step administration4
  • Available in 2 doses (0.5 mg and 1.0 mg) for adult and pediatric patients
  • No refrigeration required
References: 1. Gvoke [prescribing information]. Chicago, IL: Xeris Pharmaceuticals, Inc. 2. U.S. Food and Drug Administration. Search results for "glucagon." Drugs@FDA: FDA approved drug products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. Accessed September 13, 2019. 3. Newswanger B, Prestrelski S, Andre AD. Human factors studies of a prefilled syringe with stable liquid glucagon in a simulated severe hypoglycemia rescue situation. Expert Opin Drug Deliv. 2019;16(9):1015-1025. 4. Gvoke Pre-Filled Syringe [instructions for use]. Chicago, IL: Xeris Pharmaceuticals, Inc.